| Colin Brown, PA-C | |
|
13500 S. Pleasant Valley, Kuna, ID 83634 | |
| (208) 922-8312 | |
| Not Available |
| Full Name | Colin Brown |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 11 Years |
| Location | 13500 S. Pleasant Valley, Kuna, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386063980 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 51458 (California) | Secondary |
| 363A00000X | Physician Assistant | PA-1176 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian Medical Systems at the only private radiotherapy clinic in the Nordic region.
Griffith University will partner with a Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc. for a new vaccine that could benefit millions.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causal agent of the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more than 4.3 million lives worldwide. Even after implementing various measures, such as vaccination and social restrictions, SARS-CoV-2 and its variants of concern (VoC) leave the world's public health systems and economies in turmoil.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
Albert Einstein College of Medicine of Yeshiva University researcher Jeffrey Pollard, Ph.D., has received the prestigious Medal of Honor in Basic Science from the American Cancer Society (ACS) in recognition of his research into the critical role the tumor microenvironment plays in modulating cancer behavior, specifically the role that members of the innate immune cells called macrophages play both in normal development and in promoting tumor progression. These macrophages could hold the key to more targeted cancer treatments.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colin Brown, PA-C 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | Colin Brown, PA-C 13500 S. Pleasant Valley, Kuna, ID 83634 Ph: (208) 922-8312 |
News Archive
Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian Medical Systems at the only private radiotherapy clinic in the Nordic region.
Griffith University will partner with a Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc. for a new vaccine that could benefit millions.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causal agent of the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more than 4.3 million lives worldwide. Even after implementing various measures, such as vaccination and social restrictions, SARS-CoV-2 and its variants of concern (VoC) leave the world's public health systems and economies in turmoil.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
Albert Einstein College of Medicine of Yeshiva University researcher Jeffrey Pollard, Ph.D., has received the prestigious Medal of Honor in Basic Science from the American Cancer Society (ACS) in recognition of his research into the critical role the tumor microenvironment plays in modulating cancer behavior, specifically the role that members of the innate immune cells called macrophages play both in normal development and in promoting tumor progression. These macrophages could hold the key to more targeted cancer treatments.
› Verified 9 days ago
Mrs. Annie Johnson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 708 E Wythe Creek Ct Ste 103, Kuna, ID 83634 Phone: 208-922-5130 Fax: 208-922-5132 | |
Megan Cory Mcintyre, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 825 W Deer Flat Rd, Kuna, ID 83634 Phone: 208-922-3355 Fax: 678-553-1263 | |
Mr. Trenton Hart, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 757 E Wythe Creek Ct Ste 100, Kuna, ID 83634 Phone: 208-302-6500 Fax: 208-302-6535 | |
Alec Meyerhoeffer, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 13500 Pleasant Vly Rd, Kuna, ID 83634 Phone: 208-336-0740 | |
Ms. Michelle Renee Lucero, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 13500 S Pleasant Valley Rd, Kuna, ID 83634 Phone: 208-331-2760 | |
Kelsey Ann Ropa, Physician Assistant Medicare: Medicare Enrolled Practice Location: 13003 S Madera Pl, Kuna, ID 83634 Phone: 805-558-6526 |